Publicaciones en las que colabora con Borja Ibáñez Cabeza (43)

2024

  1. Association between subclinical atherosclerosis burden and unrecognized myocardial infarction detected by cardiac magnetic resonance in middle-aged low-risk adults

    European Heart Journal Cardiovascular Imaging, Vol. 25, Núm. 7, pp. 968-975

  2. Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors

    JACC: Cardiovascular Imaging

2023

  1. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

    European Heart Journal, Vol. 44, Núm. 39, pp. 4043-4140

  2. Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis

    Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057

  3. Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

    Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2069-2083

  4. Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study

    European heart journal, Vol. 44, Núm. 29, pp. 2698-2709

2022

  1. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

    European heart journal, Vol. 43, Núm. 39, pp. 3826-3924

  2. Bone marrow activation in response to metabolic syndrome and early atherosclerosis

    European Heart Journal, Vol. 43, Núm. 19, pp. 1809-1828

  3. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

    European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103

  4. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412

  5. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058

  6. New 3-Dimensional Volumetric Ultrasound Method for Accurate Quantification of Atherosclerotic Plaque Volume

    JACC: Cardiovascular Imaging, Vol. 15, Núm. 6, pp. 1124-1135

  7. Polypill Strategy in Secondary Cardiovascular Prevention

    The New England journal of medicine, Vol. 387, Núm. 11, pp. 967-977

2021

  1. 2020 Update of the quality indicators for acute myocardial infarction: A position paper of the Association for Acute Cardiovascular Care: The study group for quality indicators from the ACVC and the NSTE-ACS guideline group

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 224-233

  2. A novel circulating microRNA for the detection of acute myocarditis

    New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027

  3. Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes

    Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791

  4. Triglycerides and Residual Atherosclerotic Risk

    Journal of the American College of Cardiology, Vol. 77, Núm. 24, pp. 3031-3041

2020

  1. A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart

    Cell, Vol. 183, Núm. 1, pp. 94-109.e23

  2. Association Between Body Size Phenotypes and Subclinical Atherosclerosis

    The Journal of clinical endocrinology and metabolism, Vol. 105, Núm. 12

  3. Comments on the 2019 ESC guidelines on acute pulmonary embolism

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 452-456